Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Silodosin, Tadalafil Alone Versus Silodosin Plus Tadalafil as Medical Expulsive Therapy for Lower Ureteric Stones: A Prospective Randomized Placebo Controlled Study

NCT05789732 is registered in ClinicalTrials.gov with Benha University as lead sponsor.

NCT NCT05789732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05789732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Silodosin, Tadalafil Alone Versus Silodosin Plus Tadalafil as Medical Expulsive Therapy for Lower Ureteric Stones: A Prospective Randomized Placebo Controlled Study
Lead sponsor
Benha University
Phase
Not applicable
Overall status
Completed
Start date
March 30, 2022
Completion date
August 30, 2022
Enrollment
168 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lower ureteric stones, medical expulsive therapy, silodosin, tadalafil